Drug recall · December 24, 2025
Cisatracurium Besylate Injection USP recall
Why: Subpotent product:out of specification assay results observed during long term stability testing.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.
- Lots / codes
Lot#: A240438, Exp Date 1/31/26, A250125, Exp Date 8/31/26
- Quantity
- 52,340 5mL vials
- Company
- Somerset Therapeutics LLC, Somerset, NJ
- Distribution
- Nationwide in the USA
- Initiated
- November 26, 2025 · Voluntary: Firm initiated
- Classified
- December 15, 2025
- Reported
- December 24, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Cisatracurium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.